GeneWEAVE

About:

Advancing clinical microbiology with sample-in/susceptibility-out diagnostic solutions

Website: http://www.geneweave.com

Twitter/X: GeneWEAVE

Top Investors: Decheng Capital, XSeed Capital, Claremont Creek Ventures

Description:

GeneWeave Biosciences is advancing clinical microbiology with diagnostic solutions that will enable hospitals and physicians around the world to prevent drug-resistant infections, improve antibiotic stewardship and quickly determine the optimal antibiotic therapy for critical bacterial infections. The company’s innovative and proprietary Smarticles™ technology harnesses the power of biology to enable homogeneous assays that rapidly measure bacterial drug resistance without the need for enrichment, culture, or sample preparation.